Is There An Opportunity With AstraZeneca PLC’s (NASDAQ:AZN) 46% Undervaluation? AstraZeneca PLC appears undervalued by 46% based on discounted cash flow models, with its current share price around $93 signaling… Posted by MJ January 24, 2026
